Dr. Shu Yuan Liao, MD

Dr. Liao practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Liao's NPI, 1376601732, was assigned on December 5, 2006. Dr. Liao graduated from National Taiwan University College of Medicine in 1972. Dr. Liao holds California license A32172.

Dr. Liao's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Liao's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Pathology and Laboratory Services. Dmand AI also links Dr. Liao to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Liao practices. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Liao's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Liao is board certified in anatomic pathology & clinical pathology by the American Board of Pathology. Dr. Liao is licensed in California.

CMS data shows 1,261 Medicare services from Dr. Liao across 9 procedure codes in 2024, for 292 Medicare patients. Medicare paid $38,024 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 292 Medicare patients who saw Dr. Liao in 2024. The largest group is 65 to 74, with 150 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Liao's median patient age at 49, with 89% women.

Dr. Liao accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 29 papers to Dr. Liao, published from 2008 to 2016. 2009 was the busiest year, with 3. The most frequent topics are Carbonic Anhydrases, Biomarkers, Tumor and Uterine Cervical Neoplasms. Dr. Liao has published most often in Gynecol Oncol. Dr. Liao's most frequent co-authors are Robert A. Burger, MD, John P P. Fruehauf, MD and Lyuba Levine, MD.

Dmand AI links Dr. Liao to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Uterine Cervical Dysplasia, Endometrial Hyperplasia and Precancerous Conditions.

CMS Open Payments shows 37 general payments to Dr. Liao from 9 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,064.

Dmand AI lists 3 awards for Dr. Liao, most recently Top Doctors:LA Area in 2013.

Dr. Liao graduated from National Taiwan University College of Medicine in 1972.

Dr. Liao is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.